Annis Gardner Whiting Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Annis Gardner Whiting Capital Advisors's BMY Position: Q2 2026 in Review
Annis Gardner Whiting Capital Advisors increased its Bristol-Myers Squibb (BMY) stake by 10% in Q2 2026, buying an estimated $35K and bringing the position to 6,519 shares worth $376K. The position accounts for 0.06% of the portfolio, ranked #250.
Annis Gardner Whiting Capital Advisors first reported a position in BMY in Q3 2023 and has held it in 12 quarters since. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Annis Gardner Whiting Capital Advisors held 6,519 shares of Bristol-Myers Squibb worth $376K as of Q2 2026.
- Annis Gardner Whiting Capital Advisors bought 610 Bristol-Myers Squibb shares in Q2 2026, an estimated $35K.
- Bristol-Myers Squibb made up 0.06% of Annis Gardner Whiting Capital Advisors's portfolio in Q2 2026, its #250 holding.
- Annis Gardner Whiting Capital Advisors first reported a position in Bristol-Myers Squibb in Q3 2023 and has held it in 12 quarters since.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.